Alizyme has a late stage, diversified portfolio of competitive products for the treatment of obesity and type 2 diabetes, ulcerative colitis and mucositis.

Alizyme has a late stage, diversified portfolio of competitive products for the treatment of obesity and type 2 diabetes, ulcerative colitis and mucositis.
